Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Nuformix plc

NFX
Current price
0.053 GBX +0.0025 GBX (+5.00%)
Last closed 0.053 GBX
ISIN GB00BYW79Y38
Sector Healthcare
Industry Biotechnology
Exchange London Exchange
Capitalization 470 252 GBX
Yield for 12 month -80.91 %
1Y
3Y
5Y
10Y
15Y
NFX
21.11.2021 - 28.11.2021

Nuformix plc operates in the field of pharmaceutical development for treating fibrosis and oncology through drug repurposing in the United Kingdom. It offers NXP001, which has completed Phase 1 for use in oncology supportive care. The company is also developing NXP004, a novel form of Olaparib, which is in the IP generation phase for treating oncology; and NXP002 that is in pre-clinical stage for the treatment of idiopathic pulmonary fibrosis. It also has an option agreement with Oxilio Ltd. for NXP001 for oncology indications. Nuformix plc was founded in 2008 and is based in London, the United Kingdom. Address: 60 Gracechurch Street, London, United Kingdom, EC3V 0HR

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

770.53 GBX

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-3 668 320 GBX

Last Year

Current Quarter

-849 197 GBX

Last Quarter

-1 831 001 GBX

Key Figures NFX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -495 833 GBX
Operating Margin TTM
PE Ratio
Return On Assets TTM -10.04 %
PEG Ratio
Return On Equity TTM -16.96 %
Wall Street Target Price 770.53 GBX
Revenue TTM
Book Value 0.005 GBX
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -74.4 %
Dividend Yield
Gross Profit TTM 48 218 GBX
Earnings per share
Diluted Eps TTM
Most Recent Quarter I 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NFX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History NFX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation NFX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 16.9654
Price Sales TTM 47.5237
Enterprise Value EBITDA -0.438
Price Book MRQ 0.1258

Financials NFX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NFX

For 52 weeks

0.04 GBX 0.44 GBX
50 Day MA 0.098 GBX
Shares Short Prior Month
200 Day MA 0.18 GBX
Short Ratio
Shares Short
Short Percent